Search Results

You are looking at 1 - 5 of 5 items for :

  • "ectopic Cushing’s syndrome" x
  • All content x
Clear All
Free access

Takako Araki, Ning-Ai Liu, Yukiko Tone, Daniel Cuevas-Ramos, Roy Heltsley, Masahide Tone, and Shlomo Melmed

). Subcellular mechanisms for ectopic Cushing’s syndrome are poorly defined. ACTH produced by post-translational cleavage from the proopiomelanocortin (POMC) precursor is abundantly expressed in pituitary corticotroph cells and in the hypothalamus ( Stevens

Free access

Luis G Perez-Rivas, Andrea Oßwald, Thomas Knösel, Kristin Lucia, Christian Schaaf, Michael Hristov, Julia Fazel, Thomas Kirchner, Felix Beuschlein, Martin Reincke, and Marily Theodoropoulou

-mediated human POMC expression in ectopic Cushing’s syndrome . Endocrine-Related Cancer 23 857 – 870 . ( doi:10.1530/ERC-16-0206 ) Coates PJ Doniach I Howlett TA Rees LH Besser GM 1986 Immunocytochemical study of 18 tumours

Free access

Georgios K Dimitriadis, Anna Angelousi, Martin O Weickert, Harpal S Randeva, Gregory Kaltsas, and Ashley Grossman

similar endocrine tumour-derived PNS ( Table 2 ). Table 2 Ectopic Cushing’s syndrome (CS): differences in clinical, laboratory and radiological features compared to eutopic secretion. Syndrome Mediator Tumour Clinical

Free access

Yulong Li and William F Simonds

from primary thymic or bronchial NET is rare. Adrenocorticotropic hormone (ACTH) secreting and growth hormone-releasing hormone (GHRH) secreting thymic tumors have been reported in MEN1 patients resulting in ectopic Cushing’s syndrome and acromegaly

Free access

Lucieli Ceolin, Marta Amaro da Silveira Duval, Antônio Felippe Benini, Carla Vaz Ferreira, and Ana Luiza Maia

, can rarely cause paraneoplastic Cushing’s syndrome (0.7% cases), accounting for up to 2–6% of ectopic Cushing’s syndrome cases ( Barbosa et al. 2005 ). Until recently, the management of this challenging situation, associated to extreme morbidity and